213 related articles for article (PubMed ID: 8014475)
1. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W
J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475
[TBL] [Abstract][Full Text] [Related]
2. Localization of cathepsin B in two human lung cancer cell lines.
Erdel M; Trefz G; Spiess E; Habermaas S; Spring H; Lah T; Ebert W
J Histochem Cytochem; 1990 Sep; 38(9):1313-21. PubMed ID: 2201737
[TBL] [Abstract][Full Text] [Related]
3. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy.
Calkins CC; Sameni M; Koblinski J; Sloane BF; Moin K
J Histochem Cytochem; 1998 Jun; 46(6):745-51. PubMed ID: 9603786
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
[TBL] [Abstract][Full Text] [Related]
5. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
6. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
[TBL] [Abstract][Full Text] [Related]
8. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
Lenarcic B; Krizaj I; Zunec P; Turk V
FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
Werle B; Jülke B; Lah T; Spiess E; Ebert W
Br J Cancer; 1997; 75(8):1137-43. PubMed ID: 9099961
[TBL] [Abstract][Full Text] [Related]
10. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
11. The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B.
Ritonja A; Coetzer TH; Pike RN; Dennison C
Comp Biochem Physiol B Biochem Mol Biol; 1996 Jun; 114(2):193-8. PubMed ID: 8759291
[TBL] [Abstract][Full Text] [Related]
12. Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.
Yoon MC; Solania A; Jiang Z; Christy MP; Podvin S; Mosier C; Lietz CB; Ito G; Gerwick WH; Wolan DW; Hook G; O'Donoghue AJ; Hook V
ACS Chem Biol; 2021 Sep; 16(9):1628-1643. PubMed ID: 34416110
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
[TBL] [Abstract][Full Text] [Related]
15. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W
Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis.
Krepela E; Veselý P; Chaloupková A; Zicha D; Urbanec P; Rasnick D; Vicar J
Neoplasma; 1989; 36(5):529-40. PubMed ID: 2812149
[TBL] [Abstract][Full Text] [Related]
17. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H.
Jerala R; Kroon-Zitko L; Popovic T; Turk V
Eur J Biochem; 1994 Sep; 224(3):797-802. PubMed ID: 7925405
[TBL] [Abstract][Full Text] [Related]
18. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.
Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA
Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue.
Werle B; Ebert W; Klein W; Spiess E
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):157-64. PubMed ID: 7612192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]